Egypt vs Madagascar: Access to anti-retroviral drugs, female
Egypt
46.0%
in 2024
Madagascar
39.0%
in 2024
Egypt rank
125th
Madagascar rank
128th
Access to anti-retroviral drugs, female over time
- Egypt
- Madagascar
How they compare
Egypt currently reports 46.0% against 39.0% in Madagascar, a difference of 7.0%.
That makes Egypt's figure about 1.2 times Madagascar's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Madagascar ahead.
Egypt ranks 125th and Madagascar ranks 128th of 141 countries.
Across the 3 decades both report, Egypt averaged higher in 2 and Madagascar in 1.
Head to head by decade
| Decade | Egypt | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 0.4% | 0.3% | Madagascar |
| 2010s | 14.0% | 4.5% | 9.5% | Egypt |
| 2020s | 36.8% | 24.6% | 12.2% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Egypt or Madagascar?
- Egypt, at 46.0% against 39.0% in Madagascar as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Egypt and Madagascar?
- 7.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Egypt and Madagascar rank globally for access to anti-retroviral drugs, female?
- Egypt ranks 125th and Madagascar ranks 128th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.